Drug Trial Radar · NCT07728721
Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
175
Planned (sponsor's estimate)
Start
Aug 25, 2026
Primary completion
Apr 10, 2028
Study completion Jul 25, 2028
Sponsor
- Lead sponsor
- Haisco Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults with idiopathic pulmonary fibrosis who are at least 40 years old. The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.
Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
Interventions
HSK50042 dose 1Drug
HSK50042 taken orally once daily in the morning for 26 weeks.
HSK50042 dose 2Drug
HSK50042 taken orally once daily in the morning for 26 weeks.
HSK50042 dose 3Drug
HSK50042 taken orally once daily in the morning for 26 weeks.
PlaceboDrug
Placebo matching HSK50042 taken orally once daily in the morning for 26 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change from baseline in forced vital capacity (FVC) at week 12Time frame: week 12
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.